background
rhinoviru
c
import
pathogen
asthmat
nonasthmat
children
hospitalis
episod
wheez
previou
studi
respiratori
virus
shown
sever
host
cytokin
correl
durat
hospitalis
yet
investig
children
rvc
infect
determin
nasal
cytokin
profil
children
investig
relationship
rvc
load
clinic
outcom
flock
nasal
swab
collect
children
age
month
present
emerg
depart
princess
margaret
hospit
clinic
diagnosi
acut
wheez
acut
upper
respiratori
tract
viral
infect
rvc
load
determin
quantit
rtpcr
cytokin
profil
characteris
commerci
human
cytokin
panel
rvc
commonli
detect
viru
preschoolag
children
hospitalis
episod
wheez
rvc
load
significantli
differ
asthmat
nonasthmat
patient
group
show
cytokin
profil
howev
respons
cytokin
elev
rvcinfect
children
preexist
asthma
neither
rvc
load
specif
cytokin
associ
ill
sever
studi
medic
attend
rvcinduc
wheez
characteris
inflammatori
pattern
independ
viral
load
therapeut
intervent
aim
modul
host
respons
follow
infect
rhinovirus
rv
frequent
detect
virus
preschoolag
children
year
hospitalis
respiratori
wheez
rhinoviru
c
rvc
disproportion
commonli
detect
three
rv
speci
particular
import
strongli
associ
asthmarel
hospitalis
rvassoci
earli
wheez
episod
independ
risk
factor
recurr
wheez
asthma
incept
factor
contribut
rvassoci
wheez
ill
complet
elucid
appear
littl
associ
viral
load
evid
accumul
host
immun
respons
may
import
factor
predict
clinic
outcom
follow
infect
howev
littl
data
exist
nasal
cytokin
profil
hospitalis
children
follow
rvc
infect
cytokin
profil
respiratori
virus
associ
durat
hospitalis
knowledg
yet
describ
rvc
data
suggest
asthmat
patient
infect
rv
respond
differ
nonasthmat
patient
human
challeng
studi
use
genotyp
within
rva
speci
report
differ
cytokin
profil
asthmat
nonasthmat
patient
rvb
infect
associ
lower
level
cytokin
np
swab
vtm
thaw
vortexmix
nucleic
acid
extract
vtm
use
semiautom
magmax
magnet
beadbas
purif
system
thermofish
sydney
nsw
australia
nucleic
acid
detect
use
multiplex
doubl
realtim
rtpcr
influenza
b
c
virus
flua
flub
fluc
parainfluenza
viru
piv
rsva
b
coronavirus
human
metapneumoviru
hmpv
human
bocaviru
hbov
human
adenovirus
hadv
everi
multiplex
pcr
run
perform
includ
posit
control
nucleic
acid
extract
pcr
reaction
inhibitor
detect
includ
neg
control
everi
sampl
detect
contamin
rv
screen
genotyp
complet
previous
describ
briefli
primer
target
bp
region
untransl
region
utr
rv
use
perform
seminest
pcr
secondround
pcr
product
visualis
gel
electrophoresi
pcr
product
treat
exosapit
thermo
fisher
scientif
australia
prior
sequenc
use
bigdy
termin
cycl
sequenc
kit
thermo
fisher
scientif
australia
rv
speci
c
assign
confirm
sequenc
rv
posit
sampl
bp
code
region
previous
describ
briefli
cycl
sequenc
perform
use
bigdy
termin
cycl
sequenc
kit
thermo
fisher
scientif
australia
accord
manufactur
protocol
follow
cycl
sequenc
unincorpor
dye
termin
salt
purifi
use
axyprep
mag
pcr
cleanup
kit
axygen
corn
ny
usa
accord
manufactur
protocol
capillari
sequenc
perform
appli
biosystem
dna
analyz
thermo
fisher
scientif
australia
geneiou
geneiou
auckland
new
zealand
use
sequenc
data
analysi
standard
nucleotid
blast
search
viru
famili
bacteria
cell
sequenc
genbank
viral
load
determin
complet
rotor
gene
cycler
qiagen
melbourn
vic
australia
experi
includ
posit
control
neg
control
complet
triplic
detect
human
gene
glyceraldehyd
dehydrogenas
gapdh
mrna
utilis
ensur
adequ
specimen
collect
rna
extract
detect
pcr
inhibitor
measur
interferon
gamma
gmcsf
eotaxin
groa
rant
human
cytokin
panel
complet
commerci
jomar
life
research
melbourn
vic
australia
chosen
includ
cytokin
respons
characterist
pathway
includ
innat
immun
respons
data
normal
distribut
therefor
assess
nonparametr
mannwhitney
u
test
appli
compar
two
group
kruksallw
test
appli
compar
three
group
nonparametr
spearman
rank
coeffici
use
correl
result
text
tabl
present
median
interquartil
rang
statist
analysi
pvalu
consid
statist
signific
statist
analys
carri
use
spss
statist
softwar
version
ibm
inc
chicago
usa
patient
receiv
medic
treatment
symptom
children
age
consent
inform
consent
test
swab
downstream
sampl
process
given
child
parent
legal
guardian
method
experiment
protocol
approv
princess
margaret
hospit
children
human
ethic
committe
research
govern
offic
project
number
studi
enrol
children
age
month
present
ed
respiratori
wheez
classifi
asthmat
remain
classifi
nonasthmat
time
studi
case
screen
respiratori
viru
n
return
posit
test
result
rhinoviru
rv
respiratori
syncyti
viru
rsv
human
parainfluenza
viru
hpiv
frequent
figur
speciat
rv
posit
case
clearli
show
rvc
commonli
detect
rhinoviru
speci
follow
rva
interestingli
rvc
sole
pathogen
detect
n
rvc
posit
sampl
analysi
stratifi
physiciandiagnos
asthma
shown
figur
rvc
rva
remain
predomin
virus
detect
common
asthmat
nonasthmat
children
rsv
significantli
p
less
common
asthmat
group
compar
nonasthma
group
analysi
also
compar
viral
load
asthmat
nonasthmat
children
infect
rvc
alon
seen
tabl
rvc
viral
load
two
group
statist
signific
differ
length
hospit
stay
tabl
subset
n
main
studi
popul
rvc
detect
pathogen
repres
studi
sex
ratio
asthma
profil
chosen
characteris
cytokin
respons
rvcassoci
wheez
sampl
screen
rvc
determin
sequenc
confirm
sequenc
code
region
sampl
select
cytokin
studi
rvc
posit
patient
asthma
rvc
posit
patient
diagnos
asthma
none
patient
receiv
steroid
analysi
stratifi
physiciandiagnos
asthma
shown
figur
rvc
rva
remain
predomin
virus
detect
common
asthmat
nonasthmat
children
rsv
significantli
p
less
common
asthmat
group
compar
nonasthma
group
analysi
also
compar
viral
load
asthmat
nonasthmat
children
infect
rvc
alon
seen
tabl
rvc
viral
load
two
group
statist
signific
differ
length
hospit
stay
tabl
subset
n
main
studi
popul
rvc
detect
pathogen
repres
studi
sex
ratio
asthma
profil
chosen
characteris
cytokin
respons
rvcassoci
wheez
sampl
screen
rvc
determin
sequenc
confirm
sequenc
code
region
sampl
select
cytokin
studi
rvc
posit
patient
asthma
rvc
posit
patient
diagnos
asthma
none
patient
receiv
steroid
present
per
inclus
criteria
receiv
oral
corticosteroid
therapi
within
last
day
detect
rvconli
infect
ten
nasal
sampl
otherwis
healthi
commun
control
match
age
sex
includ
part
studi
howev
five
includ
analysi
five
test
posit
rv
n
rsv
n
product
chemokin
cytokin
repres
respons
examin
children
asthma
compar
healthi
control
cytokin
figur
significantli
elev
rvcinfect
children
diagnosi
asthma
howev
level
cytokin
show
signific
differ
compar
healthi
control
group
tabl
virus
x
peer
review
present
per
inclus
criteria
receiv
oral
corticosteroid
therapi
within
last
day
detect
rvconli
infect
ten
nasal
sampl
otherwis
healthi
commun
control
match
age
sex
includ
part
studi
howev
five
includ
analysi
five
test
posit
rv
n
rsv
n
product
chemokin
cytokin
repres
respons
examin
children
asthma
compar
healthi
control
cytokin
figur
significantli
elev
rvcinfect
children
diagnosi
asthma
howev
level
cytokin
show
signific
differ
compar
healthi
control
group
tabl
level
cytokin
figur
show
signific
differ
compar
control
figur
level
nasal
secret
nonrespiratori
diseas
control
rvcinfect
patient
asthma
without
asthma
level
significantli
differ
group
asthmat
nonasthmat
patient
individu
compar
control
cytokin
compris
part
respons
import
promot
secret
proinflammatori
cytokin
significantli
elev
rvcinfect
children
asthma
figur
compar
control
also
found
proinflammatori
cytokin
elev
rvcinfect
children
asthma
figur
cytokin
compris
part
respons
import
promot
secret
proinflammatori
cytokin
significantli
elev
rvcinfect
children
asthma
figur
compar
control
also
found
proinflammatori
cytokin
elev
rvcinfect
children
asthma
figur
compar
control
contrast
level
interferon
ii
iii
repres
respect
show
signific
differ
compar
control
group
figur
virus
x
peer
review
compar
control
contrast
level
interferon
ii
iii
repres
respect
show
signific
differ
compar
control
group
figur
overal
rvcinfect
children
preexist
asthma
display
cytokin
profil
characteris
elev
level
proinflammatori
respons
howev
cytokin
level
respons
interferon
respons
display
signific
chang
compar
healthi
control
studi
also
interest
characteris
nasal
cytokin
profil
rvcinfect
children
without
preexist
asthma
cytokin
show
signific
differ
compar
control
figur
furthermor
import
contributor
clearanc
viral
infect
significantli
attenu
rvcinfect
children
without
diagnosi
asthma
wherea
show
signific
differ
compar
control
figur
cytokin
figur
significantli
elev
rvcinfect
children
tabl
figur
show
signific
differ
compar
control
level
cytokin
figur
show
signific
differ
compar
healthi
control
level
proinflammatori
cytokin
significantli
elev
compar
control
figur
overal
rvcinfect
children
preexist
asthma
display
cytokin
profil
characteris
elev
level
proinflammatori
respons
howev
cytokin
level
respons
interferon
respons
display
signific
chang
compar
healthi
control
taken
togeth
data
demonstr
cytokin
profil
children
without
preexist
asthma
characteris
increas
level
proinflammatori
cytokin
reduct
unchang
level
ifn
cytokin
figur
level
interferon
ifn
nasal
secret
control
hospitalis
rvcinfect
patient
asthma
without
asthma
attenu
nonasthmat
group
control
rvcinfect
children
preexist
asthma
trend
toward
reduc
level
p
level
significantli
differ
either
patient
group
compar
control
p
studi
also
interest
characteris
nasal
cytokin
profil
rvcinfect
children
without
preexist
asthma
cytokin
show
signific
differ
compar
control
figur
furthermor
import
contributor
clearanc
viral
infect
significantli
attenu
rvcinfect
children
without
diagnosi
asthma
wherea
show
figur
level
interferon
ifn
nasal
secret
control
hospitalis
rvcinfect
patient
asthma
without
asthma
attenu
nonasthmat
group
control
rvcinfect
children
preexist
asthma
trend
toward
reduc
level
p
level
significantli
differ
either
patient
group
compar
control
p
univari
analysi
conduct
determin
influenc
viral
load
cytokin
respons
confin
inflammatori
mediat
shown
signific
differ
control
group
separ
asthma
nonasthma
patient
group
tabl
show
weak
nonsignific
relationship
select
cytokin
rvc
load
group
moreov
none
cytokin
analys
show
associ
likelihood
hospitalis
tabl
rhinovirus
shown
commonli
found
children
present
wheez
ill
increas
evid
import
trigger
asthma
exacerb
particular
rvc
implic
caus
wheez
ill
children
without
preexist
asthma
western
australia
elsewher
studi
look
viral
pathogen
present
children
present
paediatr
emerg
depart
wheez
ill
look
role
preexist
asthma
viral
load
host
inflammatori
respons
caus
ill
rhinovirus
especi
rvc
overwhelm
virus
detect
children
support
role
major
caus
respiratori
wheez
ill
preschoolag
children
present
hospit
proport
rv
group
children
similar
rang
report
publish
literatur
intern
previou
studi
western
australia
frequenc
detect
variou
respiratori
virus
includ
rvc
children
without
preexist
asthma
length
hospitalis
differ
significantli
asthmat
patient
nonasthmat
patient
howev
unusu
children
spend
hour
hospit
median
length
stay
h
asthmat
group
h
nonasthmat
group
difficult
demonstr
statist
signific
differ
studi
size
moreov
hospitalis
infrequ
could
look
inpati
outcom
measur
outpati
followup
data
howev
data
suggest
rvc
induc
rel
short
clinic
ill
asthmat
nonasthmat
children
sever
complic
consist
recent
multicentr
studi
report
children
rhinovirusonli
infect
shorter
acut
clinic
cours
compar
children
rsvonli
infect
rvc
import
caus
wheez
preschoolag
children
look
inflammatori
marker
may
identifi
pathogen
process
may
influenc
preexist
asthma
child
result
indic
asthmat
nonasthmat
rvcinfect
children
display
increas
proinflammationassoci
cytokin
cytokin
elev
group
rvcinfect
children
howev
level
cytokin
higher
children
preexist
asthma
nonasthmat
children
therefor
cytokin
consid
signatur
respons
rvc
infect
children
present
hospit
wheez
known
shape
immun
respons
allerg
asthma
previou
studi
demonstr
cytokin
mediat
recruit
inflammatori
cell
lung
ige
isotyp
class
switch
upregul
high
affin
ige
receptor
mast
cell
basophil
igedepend
mast
cell
activ
togeth
result
develop
immedi
allerg
reaction
mucu
hypersecret
elicit
detriment
effect
epitheli
integr
ciliat
cell
differenti
lead
mucu
hypersecret
well
impair
mucu
clearanc
also
like
intrins
immunolog
predisposit
children
asthma
amplifi
exist
pulmonari
environ
may
explain
level
cytokin
higher
broader
figur
rvcinfect
children
preexist
asthma
note
elev
seen
group
surpris
cytokin
respons
domin
children
without
preexist
asthma
pulmonari
environ
patient
without
known
underli
chronic
inflamm
expect
domin
earli
cytokin
respons
elev
antivir
protein
capabl
suppress
viral
replic
howev
level
cytokin
either
significantli
attenu
show
differ
compar
control
observ
differ
viral
load
patient
preexist
asthma
compar
without
quit
possibl
therefor
medic
attend
rvc
infect
children
promot
induct
cytokin
respons
turn
dampen
antivir
cytokin
respons
result
delay
viral
clearanc
prolong
airway
inflamm
interestingli
respons
cytokin
elev
rvcinfect
children
preexist
asthma
previou
studi
demonstr
high
respons
airway
epithelium
patient
sever
asthma
known
facilit
neutrophil
activ
prolifer
neutrophil
asthma
part
enhanc
product
proinflammatori
cytokin
addit
previou
studi
shown
enhanc
product
cytokin
result
airway
hyperrespons
airway
inflamm
mucu
hypersecret
releas
follow
rv
infect
contribut
pathogenesi
respiratori
diseas
recruit
inflammatori
cell
enhanc
product
experiment
human
model
asthma
exacerb
demonstr
earli
rise
respiratori
secret
tempor
associ
clinic
symptom
present
studi
found
evid
proinflammatori
cytokin
respons
broader
stronger
children
preexist
asthma
also
found
rvcinfect
children
preexist
asthma
elev
level
cytokin
taken
togeth
data
suggest
cytokin
central
immun
respons
follow
rvc
infect
children
asthma
may
respons
featur
airway
inflamm
observ
patient
group
studi
potenti
limit
firstli
one
time
point
use
measur
cytokin
viral
load
although
earli
evalu
use
acut
phase
respons
permit
insight
provid
sequenti
measur
even
though
tempt
specul
direct
associ
cytokin
concentr
ill
sever
full
burden
diseas
sole
attribut
phenomenon
cytokin
may
behav
marker
tissu
damag
without
necessarili
contribut
patholog
directli
exclud
possibl
children
classifi
nonasthmat
studi
may
fact
asthmat
yet
diagnos
therefor
observ
domin
respons
follow
rvc
infect
nonasthmat
may
fact
marker
predisposit
asthma
diagnos
asthma
children
age
six
year
studi
difficult
episod
respiratori
symptom
wheez
common
children
age
group
studi
conclus
state
cytokin
respons
specif
rvc
sinc
look
cytokin
respons
patient
either
rva
rvb
infect
lastli
epidemiolog
compon
studi
use
utr
sequenc
speci
assign
provid
greatest
sensit
minimis
risk
sampl
bia
studi
previou
experi
well
data
studi
shown
high
correl
two
method
howev
critic
pathogen
studi
confirm
speci
vp
sequenc
summari
rvc
predomin
pathogenassoci
respiratori
wheez
hospitalis
preschoolag
children
popul
caus
shortliv
clinic
ill
rvc
load
neither
risk
factor
reliabl
marker
hospitalis
follow
infect
rvc
infect
import
level
viral
replic
determin
clinic
ill
factor
viral
load
drive
clinic
cours
rvcassoci
respiratori
wheez
hospitalis
children
characteris
domin
inflammatori
respons
suggest
synergist
relationship
rvc
host
factor
genesi
wheez
furthermor
rvc
promot
intens
cytokin
respons
children
asthma
compar
children
without
asthma
induct
cytokin
mediat
recruit
activ
neutrophil
may
import
underli
pathogen
mechan
associ
rvc
diseas
children
preexist
asthma
current
futur
therapeut
intervent
aim
modul
host
respons
follow
infect
follow
avail
onlin
http
tabl
nasal
cytokin
level
healthi
nonrespiratori
diseas
control
rvc
infect
patient
asthma
without
asthma
tabl
relationship
rvc
load
inflammatori
mediat
product
nasal
secret
children
asthma
tabl
relationship
rvc
load
inflammatori
mediat
product
nasal
secret
children
without
asthma
tabl
associ
cytokin
product
hospitalis
children
hospitalis
follow
rvc
infect
use
mannwhitney
u
test
